1. Home
  2. REE vs CASI Comparison

REE vs CASI Comparison

Compare REE & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REE
  • CASI
  • Stock Information
  • Founded
  • REE 2011
  • CASI 1991
  • Country
  • REE Israel
  • CASI China
  • Employees
  • REE N/A
  • CASI N/A
  • Industry
  • REE Auto Manufacturing
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • REE Consumer Discretionary
  • CASI Health Care
  • Exchange
  • REE Nasdaq
  • CASI Nasdaq
  • Market Cap
  • REE 22.4M
  • CASI 24.9M
  • IPO Year
  • REE N/A
  • CASI 1996
  • Fundamental
  • Price
  • REE $0.86
  • CASI $1.32
  • Analyst Decision
  • REE Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • REE 2
  • CASI 1
  • Target Price
  • REE $11.75
  • CASI $4.00
  • AVG Volume (30 Days)
  • REE 1.1M
  • CASI 34.1K
  • Earning Date
  • REE 12-16-2025
  • CASI 11-28-2025
  • Dividend Yield
  • REE N/A
  • CASI N/A
  • EPS Growth
  • REE N/A
  • CASI N/A
  • EPS
  • REE N/A
  • CASI N/A
  • Revenue
  • REE $183,000.00
  • CASI $31,564,000.00
  • Revenue This Year
  • REE $327.73
  • CASI N/A
  • Revenue Next Year
  • REE $36,888.82
  • CASI N/A
  • P/E Ratio
  • REE N/A
  • CASI N/A
  • Revenue Growth
  • REE N/A
  • CASI 36.64
  • 52 Week Low
  • REE $0.53
  • CASI $1.09
  • 52 Week High
  • REE $11.72
  • CASI $6.30
  • Technical
  • Relative Strength Index (RSI)
  • REE 39.10
  • CASI 34.41
  • Support Level
  • REE $1.06
  • CASI $1.30
  • Resistance Level
  • REE $1.10
  • CASI $1.46
  • Average True Range (ATR)
  • REE 0.12
  • CASI 0.15
  • MACD
  • REE -0.05
  • CASI -0.03
  • Stochastic Oscillator
  • REE 0.03
  • CASI 3.32

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: